These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11215707)

  • 1. Combined effect of radiation and other agents: is there a synergism trap?
    Burkart W
    J Environ Pathol Toxicol Oncol; 2001; 20(1):53-8. PubMed ID: 11215707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health risks from combined exposures: mechanistic considerations on deviations from additivity.
    Burkart W; Jung T
    Mutat Res; 1998 Sep; 411(2):119-28. PubMed ID: 9806423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying health effects from the combined action of low-level radiation and other environmental agents: can new approaches solve the enigma?
    Burkart W; Finch GL; Jung T
    Sci Total Environ; 1997 Oct; 205(1):51-70. PubMed ID: 9352670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radon and lung cancer risk: an extension of the mortality follow-up of the Newfoundland fluorspar cohort.
    Villeneuve PJ; Morrison HI; Lane R
    Health Phys; 2007 Feb; 92(2):157-69. PubMed ID: 17220717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors in relation to breast cancer characterized by p53 protein expression.
    Furberg H; Millikan RC; Geradts J; Gammon MD; Dressler LG; Ambrosone CB; Newman B
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):829-35. PubMed ID: 12223426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness and limits of biological dosimetry based on cytogenetic methods.
    Léonard A; Rueff J; Gerber GB; Léonard ED
    Radiat Prot Dosimetry; 2005; 115(1-4):448-54. PubMed ID: 16381765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy.
    Brent RL
    Am J Obstet Gynecol; 2009 Jan; 200(1):4-24. PubMed ID: 19121655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.
    Valentin J;
    Ann ICRP; 2005; 35(1):1-110, iii-iv. PubMed ID: 16164984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work to save dose: contrasting effective dose rates from radon exposure in workplaces and residences against the backdrop of public and occupational regulatory limits.
    Whicker JJ; McNaughton MW
    Health Phys; 2009 Sep; 97(3):248-56. PubMed ID: 19667808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health outcomes of low-dose ionizing radiation exposure among medical workers: a cohort study of the Canadian national dose registry of radiation workers.
    Zielinski JM; Garner MJ; Band PR; Krewski D; Shilnikova NS; Jiang H; Ashmore PJ; Sont WN; Fair ME; Letourneau EG; Semenciw R
    Int J Occup Med Environ Health; 2009; 22(2):149-56. PubMed ID: 19546093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do low dose-rate bystander effects influence domestic radon risks?
    Brenner DJ; Sachs RK
    Int J Radiat Biol; 2002 Jul; 78(7):593-604. PubMed ID: 12079538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.